A practical use of noninvasive tests in clinical practice to identify high‐risk patients with nonalcoholic steatohepatitis-Reference-Cited by-同舟云学术

A practical use of noninvasive tests in clinical practice to identify high‐risk patients with nonalcoholic steatohepatitis

Published:2022-12-13 Issue:3 Volume:57 Page:304-312
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Younossi Zobair¹²³^ORCID,Alkhouri Naim⁴,Cusi Ken⁵^ORCID,Isaacs Scott⁶,Kanwal Fasiha⁷,Noureddin Mazen⁸^ORCID,Loomba Rohit⁹^ORCID,Ravendhran Natarajan¹⁰,Lam Brian²³,Nader Khalil¹¹¹²,Racila Andrei²³¹²,Nader Fatema¹²,Henry Linda²³¹²

Affiliation:

1. Inova Medicine, Inova Health System Falls Church Virginia USA

2. Liver and Obesity Research Program, Inova Health System Falls Church Virginia USA

3. Center for Liver Diseases, Department of Medicine, Inova Fairfax Medical Campus Falls Church Virginia USA

4. Arizona Liver Health Chandler Arizona USA

5. Division of Endocrinology, Diabetes and Metabolism University of Florida Gainesville Florida USA

6. Division of Endocrinology Emory University School of Medicine Atlanta Georgia USA

7. Baylor College of Medicine, Michael E.D. Bakey VA Medical Center Houston Texas USA

8. Fatty Liver Program at Cedars‐Sinai Medical Center West Hollywood California USA

9. NAFLD Research Center, Division of Gastroenterology and Hepatology, Department of Medicine University of California San Diego La Jolla California USA

10. Department of Medicine Johns Hopkins School of Medicine Baltimore Maryland USA

11. George Washington Medical Faculty Associates Washington District of Columbia USA

12. Center for Outcomes Research in Liver Diseases The Global NASH Council Washington District of Columbia USA

Funder

Siemens Healthineers

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.17346

Reference76 articles.

1. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

2. Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD

3. Epidemiology of chronic liver diseases in the USA in the past three decades

4. Prevalence of High and Moderate Risk Nonalcoholic Fatty Liver Disease Among Adults in the United States, 1999–2016

5. Prevalence of Nonalcoholic Fatty Liver Disease in the Female Population

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Knowledge about metabolic dysfunction-associated steatotic liver disease among the medical professionals from countries in the MENA region;Annals of Hepatology;2024-09

2. Predicting Liver-Related Outcomes in Steatotic Liver Disease;JAMA;2024-04-16

3. Clinical and patient‐reported outcomes in patients with chronic hepatitis B and C and non‐alcoholic fatty liver disease from real‐world practices in Saudi Arabia, Turkey and Egypt;Journal of Viral Hepatitis;2024-04-15

4. Epidemiology of NAFLD – Focus on diabetes;Diabetes Research and Clinical Practice;2024-04

5. Nonalcoholic steatohepatitis: A comprehensive updated review of risk factors, symptoms, and treatment;Heliyon;2024-04